Rep Payee Review Program

A representative payee is a person or organization appointed by the Social Security Administration (SSA) to manage a person’s SSDI or SSI benefits. SSA appoints a representative payee if they determine that a person cannot manage their Social Security benefits on their own.

In March 2018, legislation was passed by the U.S. Senate to increase independent oversight of representative payees. As a result of the Strengthening Protections for Social Security Beneficiaries Act of 2018, Disability Rights Maine now conducts representative payee reviews on behalf of the Social Security Administration.

What does the program do?
  • Reviews of Representative Payees
  • Educational Visits
  • Corrective Action Plans
  • Trainings
  • Information and Referral to Beneficiaries

This website is developed at U.S. taxpayer expense.

FAQ for Individuals

How can I report a problem with my payee?

If you have concerns about your representative payee, you should notify your local Social Security Office as soon as possible.

You may also contact Disability Rights Maine at 800.452.1948. We will discuss your concerns and/or complete a referral for a review of your payee by SSA.

Social Security FAQ for Beneficiaries

When a Payee Manages Your Money

Understanding Your Benefits

Understanding Supplemental Security Income (SSI)

FAQ for Rep Payees

Best Practices for Rep Payees

Social Security Rep Payee FAQ

Guide for Individual Rep Payees

Guide for Organizational Payees

SSA Training for Organizational Payees

Understanding Social Security Income (SSI)

What should I expect during a Representative Payee review by DRM?

COVID-19 Representative Payee Program Update

Representative Payee monitoring is ongoing during COVID-19

“However, during the COVID-19 pandemic, the state Protection and Advocacy (P&A) networks will conduct any new representative payee monitoring reviews by phone or mail to comply with the Center for Disease Control and Prevention’s social distancing guidelines. The P&As are also completing pending reviews initiated before the COVID-19 pandemic.” -, April 9, 2020